CLASSIFICATION
Glycoprotein Cytokine
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Drogsan
WAREHOUSE
International Warehouse 2
SUBSTANCE
Erythropoietin
Indications for Dropoetin:
Dropoetin is expertly formulated to treat anemia associated with chronic kidney failure, effectively supporting both pediatric and adult patients undergoing hemodialysis or peritoneal dialysis. This powerful medication is also recommended for adults suffering from severe renal-derived anemia who display clinical symptoms but have not yet begun dialysis.
Additionally, Dropoetin plays a vital role in managing anemia in adult cancer patients (with non-myeloid malignancies) undergoing chemotherapy, significantly reducing their reliance on blood transfusions.
In HIV-infected adults undergoing zidovudine therapy, Dropoetin is indicated for managing anemia when endogenous levels are ?500 mU/ml.
For adults with moderate anemia (hematocrit levels of 33-39%, hemoglobin levels of 10-13 g/dL) scheduled for major elective surgery and anticipated to require more blood than can be collected through autologous means, Dropoetin is prescribed to facilitate autologous blood collection and minimize the need for allogeneic blood transfusions. This treatment is recommended only when blood conservation methods are insufficient for surgeries expected to require a significant blood volume (4 or more units for females or 5 or more units for males).
Dropoetin is also beneficial for enhancing erythropoiesis during the perioperative period, helping to reduce the likelihood of allogeneic blood transfusions and correct postoperative anemia in adult patients without iron deficiency undergoing major elective orthopedic surgeries. This application is limited to patients with moderate anemia (e.g., Hb 10-13 g/dL) lacking access to autologous predonation programs and who are expected to experience moderate blood loss (900 to 1800 ml).
Finally, Dropoetin is indicated for treating anemia in patients with Low or Intermediate 1-risk Myelodysplastic Syndrome (MDS), specifically for those with hemoglobin levels below 10 g/dL.
Using Dropoetin:
Administer Dropoetin exactly as directed by your healthcare provider. Always refer to the medication label for precise dosing instructions. An informative Medication Guide accompanies Dropoetin; please read it thoroughly and keep it handy for future reference when refilling your prescription.
Dropoetin is typically given via injection in a doctor?s office, hospital, or clinic. If you plan to self-administer Dropoetin at home, a healthcare professional will provide you with detailed instructions on its proper use, ensuring you understand the procedure. Always adhere to the guidance provided to you, and reach out to your healthcare provider if you have any questions.
When preparing your dose, follow the demonstrated techniques to prevent contamination of the vial, syringe, or medication. Avoid touching the rubber stopper of the vial or the syringe needle with your fingers.
Always confirm that you have drawn the correct dose before administration.
Do not shake Dropoetin, and do not use it if it has been shaken or frozen.
Avoid diluting or mixing Dropoetin with other solutions unless specifically directed by your physician.
If utilizing a single-dose vial, dispose of any unused medication after taking your dose. Consult your doctor, pharmacist, or healthcare provider regarding the disposal of single-dose vials.
Refrain from using Dropoetin if it appears cloudy, discolored, contains particles, or if the vial is damaged or cracked.
Store Dropoetin, along with syringes and needles, out of reach of children and pets. Never reuse needles, syringes, or other supplies. Inquire with your healthcare provider about correct disposal methods for these items, and adhere to all local disposal regulations.
Continue taking Dropoetin even if you feel well, and ensure you do not miss any doses. If you do miss a dose, contact your doctor as soon as possible.
Feel free to reach out to your healthcare provider with any questions regarding the use of Dropoetin.
Dropoetin Side Effects:
The following serious adverse effects are discussed in more detail in other sections of the label:
- Increased Mortality
- Myocardial Infarction
- Stroke
- Thromboembolism
- Higher mortality risk and/or increased chance of tumor progression or recurrence in cancer patients
- Hypertension
- Seizures
- Pure Red Cell Aplasia (PRCA)
- Severe allergic reactions